Cardiovascular risk factors in patients with first-episode psychosis in Sao Paulo, Brazil

Carregando...
Imagem de Miniatura
Citações na Scopus
14
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Citação
GENERAL HOSPITAL PSYCHIATRY, v.34, n.3, p.268-275, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective: The objective was to evaluate the cardiovascular profile of first-episode psychosis patients in Sao Paulo, Brazil, an issue that has not been sufficiently explored in low-/middle-income countries. Method: A cross-sectional study was performed 1 to 3 years after an initial, larger survey that assessed first-episode psychosis in sao Paulo. We evaluated cardiovascular risk factors and lifestyle habits using standard clinical examination and laboratory evaluation. Results: Of 151 contacted patients, 82 agreed to participate (mean age=35 years; 54% female). The following diagnoses were found: 20.7% were obese, 29.3% had hypertension, 39.0% had dyslipidemia, 19.5% had metabolic syndrome, and 1.2% had a >20% 10-year risk of coronary heart disease based on Framingham score. Also, 72% were sedentary, 25.6% were current smokers, and 7.3% reported a heavy alcohol intake. Conclusion: Compared to other samples, ours presented a distinct profile of higher rates of hypertension and diabetes (possibly due to dietary habits) and lower rates of smoking and alcohol intake (possibly due to higher dependence on social support). Indirect comparison vs. healthy, age-matched Brazilians revealed that our sample had higher frequencies of hypertension, diabetes and metabolic syndrome. Therefore, we confirmed a high cardiovascular risk in first-episode psychosis in Brazil. Transcultural studies are needed to investigate to which extent lifestyle contributes to such increased risk.
Palavras-chave
Psychosis, Schizophrenia, Cardiovascular disease, Lifestyle habits, Hypertension, Diabetes
Referências
  1. Attux C, 2007, REV BRAS PSIQUIATR, V29, P346, DOI 10.1590/S1516-44462006005000061
  2. Attux C, 2011, REV BRAS PSIQUIATR, V33, P117
  3. Birkenaes AB, 2007, J CLIN PSYCHIAT, V68, P917
  4. Brown S, 1997, BRIT J PSYCHIAT, V171, P502, DOI 10.1192/bjp.171.6.502
  5. Brown S, 2010, BRIT J PSYCHIAT, V196, P116, DOI 10.1192/bjp.bp.109.067512
  6. Citrome Leslie, 2005, J Psychopharmacol, V19, P102, DOI 10.1177/0269881105059505
  7. Faulkner G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005148.pub2
  8. Ferreira SRG, 2009, REV SAUDE PUBL, V43, P98
  9. Florindo AA, 2009, REV SAUDE PUBL, V43, P65
  10. Foley DL, 2011, ARCH GEN PSYCHIAT, V68, P609, DOI 10.1001/archgenpsychiatry.2011.2
  11. Fusar-Poli P, 2009, PERSPECT PSYCHIATR C, V45, P87, DOI 10.1111/j.1744-6163.2009.00202.x
  12. Gigante DP, 2009, REV SAUDE PUBL, V43, P83
  13. Grundy SM, 2005, ARTERIOSCL THROM VAS, V25, P2243, DOI 10.1161/01.ATV.0000189155.75833.c7
  14. Hallal PC, 2003, MED SCI SPORT EXER, V35, P1894, DOI 10.1249/01.MSS.0000093615.33774.0E
  15. Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11
  16. Heiskanen T, 2003, J CLIN PSYCHIAT, V64, P575
  17. Hennekens CH, 2007, J CLIN PSYCHIAT, V68, P4
  18. Iqbal R, 2008, CIRCULATION, V118, P1929, DOI 10.1161/CIRCULATIONAHA.107.738716
  19. KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261
  20. Kelly C, 1999, AM J PSYCHIAT, V156, P1751
  21. Kilbourne AM, 2007, PSYCHOSOMATICS, V48, P412, DOI 10.1176/appi.psy.48.5.412
  22. Kim SH, 2009, J PSYCHIAT RES
  23. Mackin P, 2007, BRIT J PSYCHIAT, V191, P23, DOI 10.1192/bjp.bp.106.031716
  24. Malta DC, 2008, J BRAS PNEUMOL, V36, P75
  25. McCreadie R, 1998, BRIT MED J, V317, P784
  26. McCreadie RG, 2003, BRIT J PSYCHIAT, V183, P534, DOI 10.1192/bjp.183.6.534
  27. Menezes Paulo R, 2007, Br J Psychiatry Suppl, V51, ps102, DOI 10.1192/bjp.191.51.s102
  28. Menezes PR, 2004, SOC PSYCH PSYCH EPID, V39, P212, DOI 10.1007/s00127-004-0730-z
  29. Myers MG, 2010, HYPERTENSION, V55, P195, DOI 10.1161/HYPERTENSIONAHA.109.141879
  30. Nesvag R, 2010, PSYCHIAT RES, V177, P228, DOI 10.1016/j.psychres.2010.01.007
  31. Newcomer JW, 2009, J CLIN PSYCHIAT, V70, P30, DOI 10.4088/JCP.7075su1c.05
  32. Ratto LRC, 2007, REV SAUDE PUBL, V41, P510, DOI 10.1590/S0034-89102006005000039
  33. Reinert DF, 2002, ALCOHOL CLIN EXP RES, V26, P272, DOI 10.1111/j.1530-0277.2002.tb02534.x
  34. Sa Naiza Nayla Bandeira de, 2010, Cad Saude Publica, V26, P1853, DOI 10.1590/S0102-311X2010000900018
  35. Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123
  36. Samele C, 2007, SOC PSYCH PSYCH EPID, V42, P117, DOI 10.1007/s00127-006-0135-2
  37. Schmidt MI, 2009, REV SAUDE PUBL, V43, P74
  38. Schorr SG, 2009, J CLIN PSYCHOPHARM, V29, P399, DOI 10.1097/JCP.0b013e3181acceeb
  39. Seidell JC, 1997, BRIT MED BULL, V53, P238
  40. Sichieri R, 1998, EPIDEMIOLOGIA OBESID
  41. SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624
  42. Teixeira AL, 2007, EUR CHILD ADOLES PSY, V16, P67, DOI 10.1007/s00787-006-0566-z
  43. Teixeira PJR, 2007, REV BRAS PSIQUIATR, V29, P330
  44. van Winkel R, 2008, BIPOLAR DISORD, V10, P342, DOI 10.1111/j.1399-5618.2007.00520.x
  45. Vargas TS, 2011, SCI MED PORTO ALEGRE, V21, P4
  46. Verdier F, 2007, Med Trop (Mars), V67, P552
  47. Wang CY, 2010, AUST NZ J PSYCHIAT, V44, P456, DOI 10.3109/00048670903493348
  48. Wilson PWF, 1998, AM J KIDNEY DIS, V32, pS56, DOI 10.1053/ajkd.1998.v32.pm9820465
  49. Yumru M, 2007, J AFFECT DISORDERS, V98, P247, DOI 10.1016/j.jad.2006.08.009
  50. [Anonymous], 2010, DIABETES CARE S1, V33, pS62